Cyclooxygenase Assay Kits

Assay Principle

Cyclooxygenase (COX, also known as prostaglandin endoperoxide synthase or PTGS) is a bifunctional enzyme central to eicosanoid signaling, converting arachidonic acid to prostaglandin G2 through its cyclooxygenase activity and then to prostaglandin H2 through an associated peroxidase activity. A cyclooxygenase assay typically uses one of two detection formats. Colorimetric COX activity kits measure the enzyme's peroxidase component through oxidation of a colorimetric substrate, providing a straightforward absorbance-based readout compatible with tissue homogenates and purified enzyme preparations, while fluorometric kits instead couple the peroxidase activity (which requires a heme cofactor) to conversion of a non-fluorescent probe into a fluorescent product, read at approximately Ex/Em 535/587 nm, offering greater sensitivity for samples with lower COX activity. Because both formats detect the peroxidase component of COX rather than the cyclooxygenase step directly, they report overall COX enzymatic activity rather than isoform-specific cyclooxygenase turnover.

Protocol highlights and purchasing considerations

Protocol Highlights

Kits are generally validated for animal tissue homogenates and, for colorimetric formats, purified enzyme preparations, which makes this category useful for both in vivo inflammation models and in vitro enzyme kinetics or inhibitor screening work. Fluorometric kits report notably high sensitivity, with detection ranges as low as 0.03 U/L and small required sample volumes (on the order of 15 µL), while assay times run just over an hour. Because COX activity is sensitive to sample handling (the enzyme's heme cofactor and short-lived intermediates make it susceptible to degradation), fresh tissue processing and prompt homogenization are more consequential for this assay than for many of the more chemically stable metabolites covered elsewhere in this series.

Assay Kit Purchasing Considerations

The choice between colorimetric and fluorometric detection for a COX assay kit largely comes down to expected COX activity levels and available instrumentation, with fluorometric formats offering a sensitivity advantage for low-abundance samples. Because this category is heavily used in NSAID and COX-inhibitor screening, confirming that a kit's readout genuinely reflects enzymatic turnover rather than being confounded by nonspecific peroxidase activity in crude tissue homogenates is a reasonable due-diligence step, particularly when working with inflamed or diseased tissue where multiple peroxidase-active enzymes may be present. For drug discovery applications requiring isoform selectivity data (COX-1 versus COX-2), researchers should confirm whether a given kit measures total COX activity or has been validated against isoform-selective inhibitor controls, since this distinction is not always evident from a kit's product description alone. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.